These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20630700)

  • 1. [Acral lentiginous melanoma: a slow growing tumor of the second finger].
    Cellier M; Sirvain S; Fraisse T
    Presse Med; 2010 Oct; 39(10):1100-2. PubMed ID: 20630700
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acral-lentiginous melanoma: the newest subgroup of malignant melanomas of the skin].
    Panizzon R; Stieger M; Schüler G; Hardmeier T
    Schweiz Med Wochenschr; 1982 Apr; 112(17):612-8. PubMed ID: 7089511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [S-100B and MIA (melanoma inhibiting activity) serum proteins: a prospective study of their value as melanoma progression markers].
    Dornier C; Dousset B; Legras B; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2002 May; 129(5 Pt 1):739-40. PubMed ID: 12124520
    [No Abstract]   [Full Text] [Related]  

  • 4. Acral lentiginous melanoma.
    Taylor DR; South DA
    Cutis; 1980 Jul; 26(1):35-6. PubMed ID: 7389397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells.
    Uslu U; Schliep S; Schliep K; Erdmann M; Koch HU; Parsch H; Rosenheinrich S; Anzengruber D; Bosserhoff AK; Schuler G; Schuler-Thurner B
    Anticancer Res; 2017 Sep; 37(9):5033-5037. PubMed ID: 28870930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acral lentiginous nevus.
    Han KH; Cho KH
    J Dermatol; 1998 Jan; 25(1):23-7. PubMed ID: 9519605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline staging of melanoma with unknown primary site: the value of serum s100 protein and positron emission tomography.
    Oberholzer PA; Urosevic M; Steinert HC; Dummer R
    Dermatology; 2008; 217(4):351-5. PubMed ID: 18799883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100 serum level: a tumour marker for metastatic melanoma.
    Bottoni U; Izzo P; Richetta A; Mannooranparampil TJ; Devirgiliis V; Del Giudice M; Reale MG; Frati L; Calvieri S
    Melanoma Res; 2003 Aug; 13(4):427-9. PubMed ID: 12883371
    [No Abstract]   [Full Text] [Related]  

  • 9. S100 protein serum levels in cutaneous malignant melanoma.
    Seregni E; Massaron S; Martinetti A; Illeni MT; Rovini D; Belli F; Agresti R; Greco M; Cascinelli N; Bombardieri E
    Oncol Rep; 1998; 5(3):601-4. PubMed ID: 9538159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanotic pigmentation in excision scars of melanocytic and non-melanocytic skin tumors.
    Botella-Estrada R; Sanmartín O; Sevila A; Escudero A; Guillén C
    J Cutan Pathol; 1999 Mar; 26(3):137-44. PubMed ID: 10235379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acral lentiginous melanoma in situ: a study of nine cases.
    Kwon IH; Lee JH; Cho KH
    Am J Dermatopathol; 2004 Aug; 26(4):285-9. PubMed ID: 15249858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eruptive acral lentigines--a new paraneoplastic sign?
    Wolf R; Lipozencić J; Segal Z; Davidovici B
    Acta Dermatovenerol Croat; 2008; 16(3):130-2. PubMed ID: 18812061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two prognostic markers for malignant melanoma: MIA and S100 beta.
    Juergensen A; Holzapfel U; Hein R; Stolz W; Buettner R; Bosserhoff A
    Tumour Biol; 2001; 22(1):54-8. PubMed ID: 11054027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical use of p-proteasome in discriminating metastatic melanoma patients: comparative study with LDH, MIA and S100B protein.
    Henry L; Fabre C; Guiraud I; Bastide S; Fabbro-Peray P; Martinez J; Lavabre-Bertrand T; Meunier L; Stoebner PE
    Int J Cancer; 2013 Jul; 133(1):142-8. PubMed ID: 23238767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "spaghetti technique": an alternative to Mohs surgery or staged surgery for problematic lentiginous melanoma (lentigo maligna and acral lentiginous melanoma).
    Gaudy-Marqueste C; Perchenet AS; Taséi AM; Madjlessi N; Magalon G; Richard MA; Grob JJ
    J Am Acad Dermatol; 2011 Jan; 64(1):113-8. PubMed ID: 21167406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum S100 in metastatic malignant melanoma.
    Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
    Eur J Cancer; 1995 Oct; 31A(11):1898-902. PubMed ID: 8541129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acral Lentiginous Histologic Subtype and Sentinel Lymph Node Positivity in Thin Melanoma.
    Marek AJ; Ming ME; Bartlett EK; Karakousis GC; Chu EY
    JAMA Dermatol; 2016 Jul; 152(7):836-7. PubMed ID: 27096552
    [No Abstract]   [Full Text] [Related]  

  • 18. Rising levels of serum S100 protein precede other evidence of disease progression in patients with malignant melanoma.
    Jury CS; McAllister EJ; MacKie RM
    Br J Dermatol; 2000 Aug; 143(2):269-74. PubMed ID: 10951132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum markers in skin melanoma--preliminary study.
    Dumitraşcu G; Constantin C; Manda G; Hristescu S; Mărgaritescu I; Chiriţă D; Neagu M
    Roum Arch Microbiol Immunol; 2009; 68(3):125-35. PubMed ID: 20361532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The subclinical portion in the periphery of lentigo maligna and lentigo maligna melanoma].
    Michaelsen C; Breuninger H; Rassner G; Dietz K
    Hautarzt; 1990 Mar; 41(3):142-5. PubMed ID: 2345098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.